Cosmos Health (COSM) Interest Coverage Ratio (2013 - 2026)
Cosmos Health's (COSM) quarterly Interest Coverage Ratio came in at 4.86 in Q2 2026, up 28.61% on a YoY basis from 3.78 in Q2 2025, and up 5.89% quarter-over-quarter from 5.16 in Q1 2026.
Analysis
Cosmos Health (COSM) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Cosmos Health (COSM) has reported Interest Coverage Ratio for 14 consecutive years, with 4.86 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Interest Coverage Ratio rose 28.61% year-over-year to 4.86; the trailing twelve-month figure through Jun 2026 stood at 7.8 (up 42.76% YoY), and the FY2025 full-year result was 8.79, up 42.74% from the prior year.
- Interest Coverage Ratio improved to 4.86 in Q2 2026 per COSM's latest filing, from 5.16 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.41 in Q1 2022 and bottomed at 40.35 in Q4 2023.
- Historically, Interest Coverage Ratio has averaged 11.26 across 5 years, with a median of 8.93 in 2024.
- The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio surged 117.53% in 2022, then tumbled 8711.88% in 2023.
- Over 5 years, Interest Coverage Ratio stood at 11.72 in 2022, then sank by 244.29% to 40.35 in 2023, then surged by 30.51% to 28.04 in 2024, then surged by 37.88% to 17.42 in 2025, then soared by 72.12% to 4.86 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 4.86, 5.16, and 17.42 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 0.05 |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 3.02 |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 1.87 |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | -1.79 |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 5.97 |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | 579.00 |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn | -4.86 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.86 |
| Mar 31, 2026 | -5.16 |
| Dec 31, 2025 | -17.42 |
| Sep 30, 2025 | -2.72 |
| Jun 30, 2025 | -6.80 |
| Mar 31, 2025 | -4.45 |
| Dec 31, 2024 | -28.04 |
| Sep 30, 2024 | -12.35 |
| Jun 30, 2024 | -7.31 |
| Mar 31, 2024 | -10.89 |
| Dec 31, 2023 | -40.35 |
| Sep 30, 2023 | -19.95 |
| Jun 30, 2023 | -10.55 |
| Mar 31, 2023 | -19.73 |
| Dec 31, 2022 | -11.72 |
| Sep 30, 2022 | -0.66 |
| Jun 30, 2022 | -0.12 |
| Mar 31, 2022 | 0.41 |
| Dec 31, 2021 | -0.80 |
| Sep 30, 2021 | -1.36 |